TAVI后显著瓣周漏对贫血与死亡率的影响
该多中心观察性研究纳入788例TAVI患者,5.3%存在显著瓣周漏(SPL)。SPL是TAVI后3个月贫血的独立预测因素(OR 8.31,95%CI 2.06-33.50),且SPL与3个月贫血均独立关联长期死亡率(HR 1.82和2.07)。
要点
- TAVI后SPL独立预测3个月贫血,OR达8.31。
- SPL与3个月贫血均独立关联长期死亡风险升高。
- 3个月贫血使长期死亡率翻倍(HR 2.07)。
核心结论
- SPL是TAVI后3个月贫血的独立预测因素,而贫血使长期死亡率翻倍。
- 该发现部分解释了TAVI后SPL患者预后较差的原因。
研究设计与样本
- 两所大学医院的观察性分析研究,纳入2009至2018年10年间所有连续接受TAVI的患者。
- 共纳入788例患者,中位随访21.3±21.9个月。
- 采用逻辑回归确定3个月贫血的独立预测因素,Cox回归分析时间事件结局。
主要发现
- 5.3%的患者存在SPL。
- SPL是TAVI后3个月贫血的独立预测因素(OR 8.31,95%CI 2.06-33.50)。
- SPL与长期死亡率独立关联(HR 1.82,95%CI 1.16-2.85)。
- 3个月贫血与长期死亡率独立关联(HR 2.07,95%CI 1.39-3.08)。
临床怎么用
- TAVI术后应关注显著瓣周漏的发生,并将其视为贫血和长期死亡风险增高的预警信号。
- 对TAVI后存在SPL的患者,建议监测贫血情况以辅助风险分层。
局限性
- 原文未明确报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this work is to assess the relationship between significant paravalvular leak (SPL) after transcatheter aortic valve implantation (TAVI) on anaemia and their impact on prognosis. METHODS: Observational analytic study developed at two university hospitals, including all consecutive patients who underwent TAVI during a 10-year period (2009 to 2018). A logistic regression model was created to determine independent predictors of anaemia at 3 months. Time to event outcomes were analysed with Cox regression. Median follow-up was 21.3±21.9 months. RESULTS: 788 patients were included. 5.3% had SPL. SPL was an independent predictor of anaemia 3 months after TAVI (OR: 8.31, 95% CI: 2.06 to 33.50). SPL and anaemia at 3 months were independently associated with long-term mortality (HR: 1.82, 95% CI: 1.16 to 2.85; HR: 2.07, 95% CI: 1.39 to 3.08). CONCLUSION: SPL is an independent predictor of anaemia at 3 months after TAVI, a condition that doubles long-term mortality. Our findings could explain in part the worse prognosis of SPL after TAVI. Further pathophysiological studies are necessary to explain this association.
引用
- Lopez-Pais J, Lopez-Otero D, Garcia-Touchard A, et al. Impact of significant paravalvular leaks after transcatheter aortic valve implantation on anaemia and mortality. Heart. 2020. PMID: 32843495. doi:10.1136/heartjnl-2020-316941
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。